Herantis Pharma’s clinical study with Lymfactin advances to high dose level
Herantis Pharma’s clinical study with Lymfactin advances to high dose level Herantis Pharma PlcCompany release...
Search for Articles
Mar 6, 2017
Feb 13, 2017
miRagen Therapeutics Completes merger with Signal Genetics and Concurrent $40.7M Equity Financing
BOULDER, CO – February 13, 2017 – Miragen Therapeutics, Inc. (Nasdaq: MGEN), a clinical-stage biopharmaceutical company...
Feb 7, 2017
Nido Surgical Raises $1.3M Series A Led By Broadview Ventures
Nido Surgical Raises $1.3M Series A Led By Broadview Ventures BOSTON, Feb. 7, 2017 --Nido Surgical, Inc.,...
Jan 16, 2017
Remedy Granted Orphan Drug Designation
Remedy Pharmaceuticals’ CIRARA Granted Orphan Drug Designation For Treatment of Severe Cerebral Edema Caused By...
Oct 31, 2016
miRagen Therapeutics & Signal Genetics Sign Merger Agreement
October 31, 2016 - miRagen Therapeutics and Signal Genetics Sign Merger Agreement Signal Genetics, Inc....
Jul 27, 2016
InfoBionic receives Frost & Sullivan award for Innovation
July 27, 2016 Based on its recent analysis of the arrhythmia detection and monitoring market,...